Viscogliosi Brothers

Viscogliosi Brothers, established in 1999, is a New York-based investment firm specializing in venture capital, private equity, and merchant banking within the orthopedics sector of the healthcare industry. The firm focuses on investing in healthcare devices, supplies, and manufacturing, as well as pharmaceuticals and biotechnology in the life sciences sector.

Anthony G. Viscogliosi

Co-Founder and Principal

John Viscogliosi

Co-Founder and Principal

Marc Viscogliosi

Principal

11 past transactions

Stryker - Spinal Implants Business

Acquisition in 2025
Stryker - Spinal Implants Business is a unit of Stryker.

Companion Spine

Series A in 2023
Companion Spine is a spine care company that specializes in interventional therapies and technologies aimed at addressing back pain effectively and with minimal disruption. The company focuses on providing diagnostic and medical implant products that facilitate the immediate and precise identification of spinal conditions and their underlying causes. By prioritizing patient safety and comfort, Companion Spine enables individuals to manage their pain while maintaining full spinal mobility, ultimately enhancing their quality of life.

Spine BioPharma

Convertible Note in 2023
Spine BioPharma is a biotechnology company focused on developing non-surgical therapies for back pain, specifically targeting degenerative spine diseases. Its innovative approach aims to eliminate pain and restore functionality without the use of opioids. The company's lead therapeutic candidate is designed to treat degenerative disc disease, providing clinical benefits such as pain relief, functional restoration, and the potential to slow or halt the progression of the disease. Spine BioPharma is dedicated to improving the lives of individuals suffering from chronic back pain by delivering safe and effective treatments that address both pain and inflammation, ultimately enhancing overall quality of life.

Spine BioPharma

Series B in 2022
Spine BioPharma is a biotechnology company focused on developing non-surgical therapies for back pain, specifically targeting degenerative spine diseases. Its innovative approach aims to eliminate pain and restore functionality without the use of opioids. The company's lead therapeutic candidate is designed to treat degenerative disc disease, providing clinical benefits such as pain relief, functional restoration, and the potential to slow or halt the progression of the disease. Spine BioPharma is dedicated to improving the lives of individuals suffering from chronic back pain by delivering safe and effective treatments that address both pain and inflammation, ultimately enhancing overall quality of life.

Companion Spine

Series A in 2022
Companion Spine is a spine care company that specializes in interventional therapies and technologies aimed at addressing back pain effectively and with minimal disruption. The company focuses on providing diagnostic and medical implant products that facilitate the immediate and precise identification of spinal conditions and their underlying causes. By prioritizing patient safety and comfort, Companion Spine enables individuals to manage their pain while maintaining full spinal mobility, ultimately enhancing their quality of life.

Spine BioPharma

Series A in 2021
Spine BioPharma is a biotechnology company focused on developing non-surgical therapies for back pain, specifically targeting degenerative spine diseases. Its innovative approach aims to eliminate pain and restore functionality without the use of opioids. The company's lead therapeutic candidate is designed to treat degenerative disc disease, providing clinical benefits such as pain relief, functional restoration, and the potential to slow or halt the progression of the disease. Spine BioPharma is dedicated to improving the lives of individuals suffering from chronic back pain by delivering safe and effective treatments that address both pain and inflammation, ultimately enhancing overall quality of life.

Small Bone Innovations

Series F in 2010
Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Small Bone Innovations

Series C in 2008
Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Small Bone Innovations

Series B in 2005
Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Spine Next

Series D in 2004
Spine Next is a France-based biotech company established in 1999, specializing in the manufacture and marketing of orthopedic spinal implant devices designed for spinal fusion surgeries. The company is known for its Wallis system, a stabilization device that addresses degenerative disc disease without the need for vertebral fusion. In 2004, Spine Next was acquired by Abbott, further enhancing its capabilities in the orthopedic market.

Raymedica

Venture Round in 2003
Raymedica, Inc. is an emerging medical device manufacturer based in Minneapolis, Minnesota, focused on developing innovative solutions for surgical treatment of low back pain in patients who have not responded to conservative care. The company aims to enhance the quality of life for these patients worldwide by advancing the technology created by its founder, Charles D. Ray, M.D. Raymedica is currently concentrating its efforts on the PDN® prosthetic disc nucleus, designed specifically for treating low back pain associated with degenerative disc disease. This device is surgically implanted into the evacuated nucleus disc space of the lumbar spine, with the intention of increasing or maintaining disc height and restoring normal biomechanics, ultimately alleviating pain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.